A
7.65
0.14 (1.86%)
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Mixed | Bearish |
Medical Instruments & Supplies (Global) | Mixed | Mixed | |
Stock | AngioDynamics, Inc. | Bullish | Bearish |
Stockmoo Score
0.1
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Small Value |
52 Weeks Range | ||
Price Target Range | ||
High | 14.00 (HC Wainwright & Co., 83.01%) | Buy |
Median | 13.50 (76.47%) | |
Low | 13.00 (Canaccord Genuity, 69.94%) | Buy |
Average | 13.50 (76.47%) | |
Total | 2 Buy | |
Avg. Price @ Call | 7.40 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Canaccord Genuity | 17 Jul 2024 | 13.00 (69.93%) | Buy | 7.40 |
HC Wainwright & Co. | 17 Jul 2024 | 14.00 (83.01%) | Buy | 7.40 |
No data within this time range.
Date | Type | Details |
---|---|---|
03 Sep 2024 | Announcement | AngioDynamics Announces CE Mark Approval in Europe for the Auryon System |
29 Jul 2024 | Announcement | AngioDynamics to Participate in Upcoming Investor Conferences |
16 Jul 2024 | Announcement | AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results |
08 Jul 2024 | Announcement | AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |